StockData
Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH) stock

ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$103.32+1.23 (+1.20%)

Close on Nov 18, 2026Market cap $19.71BP/E 25.1Yield 0.93%

Zimmer Biomet operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Zimmer Biomet's operating cash flow for the twelve months ending Jun 30, 2026 was $1.74B, up 4.8% year over year. For fiscal 2025 it was $1.70B, up 13.2% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $1.75B in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.70B+13.2%
FY2024Dec 31, 2024$1.50B-5.2%
FY2023Dec 31, 2023$1.58B+16.6%
FY2022Dec 31, 2022$1.36B-3.4%
FY2021Dec 31, 2021$1.40B+30.6%
FY2020Dec 31, 2020$1.08B-32.2%
FY2019Dec 31, 2019$1.59B-9.2%
FY2018Dec 31, 2018$1.75B+10.4%
FY2017Dec 31, 2017$1.58B-3.1%
FY2016Dec 31, 2016$1.63B+92.1%
FY2015Dec 31, 2015$849.80M-19.9%
FY2014Dec 31, 2014$1.06B+10.1%
FY2013Dec 31, 2013$963.10M-16.4%
FY2012Dec 31, 2012$1.15B-2.1%
FY2011Dec 31, 2011$1.18B-1.4%
FY2010Dec 31, 2010$1.19B+6.8%
FY2009Dec 31, 2009$1.12B+7.6%
FY2008Dec 31, 2008$1.04B-4.3%
FY2007Dec 31, 2007$1.08B–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$447.80M+18.4%
Q1 FY2026Mar 31, 2026$359.40M-6.1%
Q4 FY2025Dec 31, 2025$517.40M+2.2%
Q3 FY2025Sep 30, 2025$418.70M+5.8%
Q2 FY2025Jun 30, 2025$378.20M+2.4%
Q1 FY2025Mar 31, 2025$382.80M+67.9%
Q4 FY2024Dec 31, 2024$506.30M-14.0%
Q3 FY2024Sep 30, 2024$395.70M+17.2%
Q2 FY2024Jun 30, 2024$369.40M+6.2%
Q1 FY2024Mar 31, 2024$228.00M-25.9%
Q4 FY2023Dec 31, 2023$588.40M+141.0%
Q3 FY2023Sep 30, 2023$337.60M-25.1%
Q2 FY2023Jun 30, 2023$347.90M+0.7%
Q1 FY2023Mar 31, 2023$307.70M-2.5%
Q4 FY2022Dec 31, 2022$244.20M-27.7%
Q3 FY2022Sep 30, 2022$450.80M+6.3%
Q2 FY2022Jun 30, 2022$345.50M-17.5%
Q1 FY2022Mar 31, 2022$315.70M+41.3%
Q4 FY2021Dec 31, 2021$337.60M+14.0%
Q3 FY2021Sep 30, 2021$424.20M+11.3%
Q2 FY2021Jun 30, 2021$419.00M–
Q1 FY2021Mar 31, 2021$223.50M-50.4%
Q4 FY2020Dec 31, 2020$296.20M-30.0%
Q3 FY2020Sep 30, 2020$381.30M-34.0%
Q2 FY2020Jun 30, 2020-$52.80M-117.5%
Q1 FY2020Mar 31, 2020$450.90M+59.0%
Q4 FY2019Dec 31, 2019$423.30M+11.5%
Q3 FY2019Sep 30, 2019$577.90M+19.4%
Q2 FY2019Jun 30, 2019$301.00M-23.5%
Q1 FY2019Mar 31, 2019$283.60M-42.2%
Q4 FY2018Dec 31, 2018$379.50M-5.8%
Q3 FY2018Sep 30, 2018$484.10M+4.4%
Q2 FY2018Jun 30, 2018$393.30M-10.7%
Q1 FY2018Mar 31, 2018$490.50M+78.1%
Q4 FY2017Dec 31, 2017$402.90M-35.8%
Q3 FY2017Sep 30, 2017$463.50M+31.5%
Q2 FY2017Jun 30, 2017$440.50M–
Q1 FY2017Mar 31, 2017$275.40M–
Q4 FY2016Dec 31, 2016$627.20M–
Q3 FY2016Sep 30, 2016$352.60M–

More Zimmer Biomet figures

See a number that looks wrong?